[
    [
        {
            "time": "2019-07-22",
            "original_text": "渝股看台｜智飞生物大股东9折让利员工持股计划，6.6亿元出售1600万股",
            "features": {
                "keywords": [
                    "智飞生物",
                    "大股东减持",
                    "员工持股计划",
                    "9折让利",
                    "6.6亿元"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "渝股看台｜智飞生物大股东9折让利员工持股计划，6.6亿元出售1600万股",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 9,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-07-22",
            "original_text": "智飞生物实控人让利员工持股计划 800名员工斥资6.6亿元认购1600万股",
            "features": {
                "keywords": [
                    "实控人蒋仁生",
                    "员工持股计划",
                    "800名员工",
                    "6.6亿元",
                    "1600万股"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "智飞生物实控人让利员工持股计划 800名员工斥资6.6亿元认购1600万股",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-07-22",
            "original_text": "智飞生物：员工持股计划接盘大股东1600万股股份",
            "features": {
                "keywords": [
                    "员工持股计划",
                    "接盘",
                    "大股东减持",
                    "1600万股"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "智飞生物：员工持股计划接盘大股东1600万股股份",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-07-22",
            "original_text": "智飞生物(300122.SZ)：实际控制人蒋仁生减持1600万股 由员工持股计划买入",
            "features": {
                "keywords": [
                    "实际控制人蒋仁生",
                    "减持",
                    "员工持股计划",
                    "1600万股"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "智飞生物(300122.SZ)：实际控制人蒋仁生减持1600万股 由员工持股计划买入",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2019-07-22",
            "original_text": "智飞生物：第二期员工持股计划受让1600万股 耗资6.6亿元",
            "features": {
                "keywords": [
                    "第二期员工持股计划",
                    "受让",
                    "1600万股",
                    "6.6亿元"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "智飞生物：第二期员工持股计划受让1600万股 耗资6.6亿元",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-07-22",
            "original_text": "[快讯]智飞生物:关于第二期员工持股计划实施进展暨公司控股股东减持股份 拟减持股份",
            "features": {
                "keywords": [
                    "第二期员工持股计划",
                    "控股股东减持",
                    "拟减持股份"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "[快讯]智飞生物:关于第二期员工持股计划实施进展暨公司控股股东减持股份 拟减持股份",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2019-07-22",
            "original_text": "智飞生物：控股股东减持1600万股，公司第二期员工持股计划接盘 减持股份",
            "features": {
                "keywords": [
                    "控股股东减持",
                    "第二期员工持股计划",
                    "接盘",
                    "1600万股"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "智飞生物：控股股东减持1600万股，公司第二期员工持股计划接盘 减持股份",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]